Continue to Site

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Merit Medical Systems

Is nanotech the future of breast implants? | MassDevice.com On Call

By Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL —Nanotechnology could hold promise for the next generation in breast implant material, said researchers.

Scientists at the University of Akron are currently developing an alternative to the standard silicone rubber implant, which according to them has a 20 to 30 percent complication rate.

The new material would be a nanostructed alternative to silicone that has the ability to deliver cancer drugs and minimize chemotherapy side effects in the 75 percent of post-mastectomy patients that choose breast reconstruction surgery.

Merit Medical gets on, off the hook with NASDAQ

By Leave a Comment

Merit Medical Systems

Merit Medical Systems Inc. (NSDQ:MMSI) got a warning letter and a reprieve within the same missive from the NASDAQ exchange after the death of one of its board members.

James Ellis was a member of the company’s audit committee until his death August 20. That left a vacant seat on the audit committee, breaking one of the stock exchange’s requirements.

Merit to increase share count by 25 percent in stock split | Funding roundup

By Leave a Comment

Merit Medical

Merit Medical Systems Inc. (NSDQ:MMSI) shareholders will soon get a 25 percent boost in the number of shares they own in the company after its board approved a 5-for-4 forward stock split, the company said today.

The split, which the company scheduled after market close on May 5, also corresponds to a proportionate reduction in equity and cash value per share. Boards often split their companies’ stock to make shares more affordable.

FDA approves two Medtronic pacemakers | Regulatory roundup

By Leave a Comment

Clearances roundup

Medtronic Inc. (NYSE:MDT) launched two pacemakers that had been delayed by regulatory snafus for months, the company said today.

The Fridley, Minn.-based company resolved a Nov. 2009 warning letter that enabled the company to win FDA approval for the Consulta and Syncra cardiac resynchronization therapy-pacemaker (CRT-P) systems.

Alere’s losses break the billion mark | Earnings roundup

By Leave a Comment

MassDevice.com Earnings Roundup

MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.

Here’s a quick rundown of a few releases over the past couple days:

Merit Medical, American Regent issue recalls

By Leave a Comment

FDA

Merit Medical Systems Inc. (NSDQ:MMSI) and American Regents Inc. both issued recalls.

Merit told its customers to immediately stop using one of the company’s vascular catheter sheaths.

The South Jordan, Utah-based company’s Prelude catheter introducer’s tip may detach during use, a failure that could allow the part to enter the bloodstream, according to the Food & Drug Administration.

Merit closes BioSphere buyout

By Leave a Comment

BSMD, MMSI logos

Merit Medical Systems Inc. (NSDQ:MMSI) closed its $96 million cash acquisition of BioSphere Medical Inc. (NSDQ:BSMD).

The buyout of the Rockland, Mass.-based embolotherapeutic device developer, announced in May, was delayed by a lawsuit brought on the company’s board by the its shareholders.

BioSphere reaches deal with shareholders over merger suit

By Leave a Comment

BSDM logo

BioSphere Medical Inc. (NSDQ:BSMD) and its shareholders reached an agreement over the company’s proposed merger with Merit Medical Systems Inc. (NSDQ:MMSI).

In a class action suit, the shareholders were attempting to get an injunction against the Merit’s $96 million purchase of BioSphere.

BioSphere shareholders expand lawsuit over Merit merger

By Leave a Comment

BSMD logo

BioSphere Medical Inc. (NSDQ:BSMD) shareholders added to their attempt to block a proposed, $96 million merger with Merit Medical Systems Inc. (NSDQ:MMSI).

In a class action suit, initially brought against the company’s board, the shareholders are attempting to get an injunction against the Merit’s purchase of BioSphere.

Merit Medical to buy BioSphere for $96 million

By Leave a Comment

BSMD, MMSI logos

Merit Medical Systems Inc. (NSDQ:MMSI) agreed to acquire BioSphere Medical Inc. (NSDQ:BSMD) for about $96 million in cash.

The deal for the Rockland, Mass.-based firm, at roughly $4.38 per share, represents a 54 percent premium over BioSphere’s $2.84 closing price May 12. Shares were up 5.6 percent to $2.00 in late-afternoon trading May 13.

Copyright © 2024 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy